Chemical activators of junctional cadherin complex regulator play a pivotal role in modifying the cellular mechanisms and pathways that directly influence the function and stability of adhesion complexes. Calcium Ionophore A23187, for instance, functions by enhancing the intracellular concentration of calcium ions, a crucial component in cadherin-mediated cell adhesion. The increased calcium influx can activate junctional cadherin complex regulator, facilitating the strengthening of cell-cell adhesion. Similarly, Thapsigargin raises intracellular calcium levels by inhibiting SERCA, thereby potentially leading to activation of junctional cadherin complex regulator through calmodulin-dependent pathways which are integral to maintaining intercellular bridges. Jasplakinolide's role in stabilizing actin filaments also contributes to the activation of junctional cadherin complex regulator, as it promotes the association between the actin cytoskeleton and cadherin-catenin complexes, thereby enhancing cell adhesion.
Further, Phorbol 12-myristate 13-acetate activates protein kinase C (PKC), which can phosphorylate and consequentially activate junctional cadherin complex regulator, a process critical for adhesion junction assembly and maintenance. Calpeptin inhibits calpain, leading to the activation of junctional cadherin complex regulator by preserving the integrity of the cytoskeleton and adhesion complexes. Forskolin, raising cAMP levels, activates junctional cadherin complex regulator via PKA-dependent pathways that influence the formation and stabilization of cell junctions. Genistein's inhibition of tyrosine kinases leads to activation by modifying phosphorylation states within the cadherin-catenin complex, which is essential for junctional integrity. The cAMP analog Dibutyryl-cAMP activates junctional cadherin complex regulator by emulating cAMP's action on PKA, influencing the stabilization of the junctional complex. Moreover, Okadaic Acid, by inhibiting protein phosphatases, enhances protein phosphorylation within the cadherin-catenin complexes, a critical step for the activation of junctional cadherin complex regulator. ML-7 contributes to activation by inhibiting MLCK, reducing contractile forces on cell junctions, which promotes stability and activates the junctional cadherin complex regulator. Cytochalasin D, by disrupting actin polymerization, activates junctional cadherin complex regulator through mechanisms that compensate for cytoskeletal disruption, thereby strengthening cell-cell adhesion. Lastly, LY294002 inhibits the PI3K/Akt pathway, which can lead to the activation of junctional cadherin complex regulator, altering cell survival signals that may enhance the dynamics of cell-cell adhesion.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore A23187 facilitates the influx of calcium ions, which can activate junctional cadherin complex regulator by promoting calcium-dependent adhesion processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin elevates intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which could lead to the activation of junctional cadherin complex regulator via calmodulin-dependent signaling pathways. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can activate junctional cadherin complex regulator by enhancing the actin cytoskeleton's association with cadherin-catenin complexes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate and activate junctional cadherin complex regulator by promoting adhesion junction assembly. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin inhibits calpain, which can lead to activation of junctional cadherin complex regulator by preserving the cytoskeleton and adhesion complex integrity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases, which can lead to activation of junctional cadherin complex regulator by altering phosphorylation states of proteins associated with cadherin-catenin complex. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can activate junctional cadherin complex regulator by mimicking the action of cAMP and activating PKA, affecting junctional complex stabilization. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, which can lead to activation of junctional cadherin complex regulator through increased phosphorylation of proteins within cadherin-catenin complexes. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 inhibits myosin light chain kinase (MLCK), which can lead to activation of junctional cadherin complex regulator by reducing contractile forces on cell junctions, thus promoting junction stability. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization, which can activate junctional cadherin complex regulator by inducing compensatory mechanisms that strengthen cell-cell adhesion. | ||||||